Circulating Extracellular Vesicles in Cardiovascular Disease.

Area of Science:

• Cardiovascular Research
• Cell Biology
• Biomarker Discovery

Background:

• Cardiovascular disease (CVD) is a major global health concern requiring advanced strategies.
• Extracellular vesicles (EVs) mediate intercellular communication, impacting cardiovascular pathophysiology.
• EVs carry bioactive molecules and are released by various cardiovascular cell types.

Purpose of the Study:

• To review the multifaceted roles of EVs in cardiovascular disease (CVD).
• To highlight the potential of EVs as diagnostic and prognostic biomarkers for CVD.
• To discuss emerging EV-based therapeutic strategies for cardiovascular conditions.

Main Methods:

• Literature review of studies on extracellular vesicles and cardiovascular disease.
• Analysis of EV composition (miRNAs, proteins, lipids) and cellular origins.
• Examination of current and future applications of EVs in CVD diagnosis and therapy.

Main Results:

• EVs significantly influence vascular remodeling, inflammation, and immune responses in CVD.
• Circulating EVs show promise as non-invasive biomarkers for CVD diagnosis and prognosis.
• Engineered EVs offer potential for targeted drug delivery in treating cardiovascular diseases like atherosclerosis and myocardial infarction.

Conclusions:

• EVs are critical mediators in cardiovascular disease (CVD) and hold significant potential for precision medicine.
• Standardization of EV isolation and characterization is crucial for clinical translation.
• Further research into EV roles and applications can advance cardiovascular care.